Agenus Inc.
(NASDAQ : AGEN)

( )
AGEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.02%73.340.9%$603.58m
CELGCelgene Corporation
2.24%130.291.1%$443.49m
AMGNAmgen Inc.
1.14%170.071.1%$408.88m
BIIBBiogen Inc.
1.26%286.721.2%$356.69m
REGNRegeneron Pharmaceuticals, Inc.
1.90%478.652.7%$320.91m
VRTXVertex Pharmaceuticals Incorporated
4.34%155.481.9%$240.46m
ALXNAlexion Pharmaceuticals, Inc.
3.58%138.201.9%$220.20m
ILMNIllumina, Inc.
2.14%194.763.5%$214.91m
INCYIncyte Corporation
2.46%123.862.6%$133.37m
KITEKite Pharma, Inc.
1.52%135.9516.1%$128.55m
CLVSClovis Oncology, Inc.
1.24%72.0818.0%$127.98m
TSROTESARO, Inc.
1.48%120.6214.7%$126.99m
AAgilent Technologies, Inc.
1.93%62.931.5%$121.42m
BMRNBioMarin Pharmaceutical Inc.
1.07%81.464.4%$105.18m
SRPTSarepta Therapeutics, Inc.
3.41%36.9519.8%$99.21m

Company Profile

Agenus, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its core technology portfolio consists of Saponin platform and Heat Shock Protein platform. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.